Nektar Therapeutics (NKTR) Change in Inventory (2010 - 2024)
Nektar Therapeutics (NKTR) recorded quarterly Change in Inventory of -$1.3 million in Q4 2024, down 960.98% quarter-over-quarter from -$123000.0 in Q3 2024, and down 21.85% on a YoY basis from -$1.7 million in Q1 2024.
Nektar Therapeutics (NKTR) Change in Inventory (2010 - 2024) Analysis & Trends
Nektar Therapeutics' Change in Inventory history runs 15 years deep, the most recent figure standing at -$1.3 million for Q4 2024.
- In Q4 2024, Change in Inventory fell 21.85% year-over-year to -$1.3 million; the TTM figure through Sep 2025 stood at -$1.3 million (down 396.2% YoY), while the FY2024 annual figure was -$497000.0, up 28.9% from the prior year.
- Change in Inventory was -$1.3 million for Q4 2024 at Nektar Therapeutics, down from -$123000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $2.4 million in Q4 2020 to a low of -$2.4 million in Q3 2023.
- Historically, Change in Inventory has averaged $267050.0 across 5 years, with a median of $389500.0 in 2020.
- Biggest YoY gain for Change in Inventory was 570.38% in 2023; the steepest drop was 838.62% in 2023.
- A 5-year view of Change in Inventory shows it stood at $2.4 million in 2020, then slumped by 80.38% to $471000.0 in 2021, then plunged by 69.21% to $145000.0 in 2022, then tumbled by 838.62% to -$1.1 million in 2023, then slipped by 21.85% to -$1.3 million in 2024.
- The last three Change in Inventory figures came in at -$1.3 million (Q4 2024), -$123000.0 (Q3 2024), and -$212000.0 (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Nektar Therapeutics | 1.51 Bn | 939.55 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1.31 Mn |
| Dec 31, 2024 | -1.31 Mn |
| Sep 30, 2024 | -123,000.00 |
| Sep 30, 2024 | -123,000.00 |
| Jun 30, 2024 | -212,000.00 |
| Jun 30, 2024 | -212,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | -1.07 Mn |
| Dec 31, 2023 | -1.07 Mn |
| Sep 30, 2023 | -2.37 Mn |
| Sep 30, 2023 | -2.37 Mn |
| Jun 30, 2023 | 754,000.00 |
| Jun 30, 2023 | 754,000.00 |
| Mar 31, 2023 | 1.99 Mn |
| Mar 31, 2023 | 1.99 Mn |
| Dec 31, 2022 | 145,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Sep 30, 2022 | 2.09 Mn |
| Sep 30, 2022 | 2.09 Mn |